ADAMAS PHARMACEUTICALS INC's ticker is ADMS and the CUSIP is 00548A106. A total of 67 filers reported holding ADAMAS PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 0.45 and the average weighting 0.3%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2021 | $128,000 | -28.1% | 26,000 | -22.8% | 0.00% | – |
Q2 2021 | $178,000 | -41.8% | 33,700 | -47.1% | 0.00% | – |
Q1 2021 | $306,000 | +10.9% | 63,700 | 0.0% | 0.00% | – |
Q4 2020 | $276,000 | +5.3% | 63,700 | 0.0% | 0.00% | – |
Q3 2020 | $262,000 | +21.3% | 63,700 | -24.4% | 0.00% | – |
Q2 2020 | $216,000 | -12.9% | 84,300 | -1.7% | 0.00% | – |
Q1 2020 | $248,000 | -5.0% | 85,739 | +24.4% | 0.00% | – |
Q4 2019 | $261,000 | -13.3% | 68,939 | +17.0% | 0.00% | – |
Q3 2019 | $301,000 | -17.5% | 58,928 | +0.2% | 0.00% | – |
Q2 2019 | $365,000 | +305.6% | 58,797 | +366.8% | 0.00% | – |
Q1 2019 | $90,000 | -15.9% | 12,597 | +0.8% | 0.00% | – |
Q4 2018 | $107,000 | -68.0% | 12,497 | -25.0% | 0.00% | – |
Q3 2018 | $334,000 | -21.8% | 16,661 | +0.8% | 0.00% | – |
Q2 2018 | $427,000 | – | 16,532 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
C Partners Holding GmbH | 1,662,128 | $29,037,000 | 9.28% |
GREAT POINT PARTNERS LLC | 608,650 | $10,645,000 | 4.68% |
Opaleye Management Inc. | 255,000 | $4,460,000 | 2.07% |
EMERALD MUTUAL FUND ADVISERS TRUST | 326,530 | $5,721,000 | 0.47% |
Granite Point Capital Management, L.P. | 61,813 | $1,076,000 | 0.39% |
WALL STREET ASSOCIATES | 225,000 | $3,935,000 | 0.37% |
EMERALD ADVISERS, LLC | 322,631 | $5,652,000 | 0.28% |
Spark Investment Management LLC | 75,500 | $1,317,000 | 0.18% |
TFS CAPITAL LLC | 98,443 | $1,722,000 | 0.17% |
PRIVATE ASSET MANAGEMENT INC | 47,690 | $834,000 | 0.14% |